- CEO
- Christopher Devall
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 725 Fifth Avenue New York NY United States of America
- IPO Date
- Aug 20, 2024
- Business
- SIM Acquisition Corp. I (SIMAW) operates as a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, primarily targeting private high-quality, growth-oriented healthcare companies; it offers no current operational products or services beyond this SPAC structure, with securities traded on Nasdaq including Class A ordinary shares (SIMA), units (SIMAU) and redeemable warrants (SIMAW). Incorporated in 2024 as a Cayman Islands exempt company and headquartered at 78 SW 7th Street, Suite 500, Miami, Florida, the company functions as a subsidiary of SIM Sponsor 1 LLC and maintains geographic operations centered in the United States while pursuing targets globally in the healthcare sector. Erich Spangenberg serves as Chairman and Chief Executive Officer, David Kutcher as Director and Chief Financial Officer, with the board including Dr. Toby Cosgrove, former CEO of the Cleveland Clinic, and Vince Capone. In recent developments, the company completed a $230 million initial public offering in July 2024, priced at $10.00 per unit with Cantor Fitzgerald as lead underwriter; and in September 2025, director Janine Grasso resigned from the board, audit committee and compensation committee for personal reasons, with no disagreements noted, prompting a search for a new independent director.